Oral contraceptives, insulin resistance and ischemic vascular disease. 1990

E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
INSERM Unite 21, Villejuif, France.

From a large prospective study on diabetes risks, 1112 professionally active, non-menopausal, non-pregnant, healthy women were cross-sectionally analysed according to their use of oral contraception. After adjustment for age, weight and diabetes risk factors, those taking the pill, compared to those who did not, had significantly higher fasting serum insulin, triglycerides and 2-h 75 g OGTT blood glucose levels. The insulin-resistance markers which have recently been cited as ischemic vascular disease risk factors should be carefully monitored in pill users.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
January 1968, University of Michigan Medical Center journal,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
January 1982, Epidemiologic reviews,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
January 1989, Epidemiologic reviews,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
July 1985, Obstetrics and gynecology,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
August 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
January 1978, Terapevticheskii arkhiv,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
April 1968, Lancet (London, England),
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
May 1977, The Western journal of medicine,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
March 1982, Obstetrics and gynecology,
E Eschwége, and A Fontbonne, and D Simon, and N Thibult, and B Balkau, and M Saint-Paul, and P Garnier, and C Senan, and L Papoz
January 1992, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!